Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation.

Int J Cancer 2018 08 8;143(3):515-526. Epub 2018 Mar 8.

Virginia G. Piper Center for Personal Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ.

Immuno-proteomic screening has identified several tumor-associated autoantibodies (AAb) that may have diagnostic capacity for invasive epithelial ovarian cancer, with AAbs to P53 proteins and cancer-testis antigens (CTAGs) as prominent examples. However, the early detection potential of these AAbs has been insufficiently explored in prospective studies. We performed ELISA measurements of AAbs to CTAG1A, CTAG2, P53 and NUDT11 proteins, for 194 patients with ovarian cancer and 705 matched controls from the European EPIC cohort, using serum samples collected up to 36 months prior to diagnosis under usual care. CA125 was measured using electrochemo-luminiscence. Diagnostic discrimination statistics were calculated by strata of lead-time between blood collection and diagnosis. With lead times ≤6 months, ovarian cancer detection sensitivity at 0.98 specificity (SE98) varied from 0.19 [95% CI 0.08-0.40] for CTAG1A, CTAG2 and NUDT1 to 0.23 [0.10-0.44] for P53 (0.33 [0.11-0.68] for high-grade serous tumors). However, at longer lead-times, the ability of these AAb markers to distinguish future ovarian cancer cases from controls declined rapidly; at lead times >1 year, SE98 estimates were close to zero (all invasive cases, range: 0.01-0.11). Compared to CA125 alone, combined logistic regression scores of AAbs and CA125 did not improve detection sensitivity at equal level of specificity. The added value of these selected AAbs as markers for ovarian cancer beyond CA125 for early detection is therefore limited.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.31335DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019150PMC
August 2018
93 Reads

Article Mentions


Provided by Crossref Event Data
twitter
Twitter: BVMurciasalud
February 28, 2018, 3:00 am EST
twitter
Twitter: LaViaProduccion
February 27, 2018, 9:02 am EST
twitter
Twitter: Fibrograna
February 27, 2018, 5:44 am EST
twitter
Twitter: Claudiomendez
February 26, 2018, 9:03 pm EST
twitter
Twitter: Angela_HR_dn
February 26, 2018, 8:01 am EST
twitter
Twitter: Mjsanchezperez
February 26, 2018, 5:42 am EST
twitter
Twitter: EASPsalud
February 26, 2018, 4:01 am EST
twitter
Twitter: BiblioEASP
February 26, 2018, 2:39 am EST

Publication Analysis

Top Keywords

ovarian cancer
20
early detection
12
detection sensitivity
8
ctag1a ctag2
8
markers ovarian
8
lead times
8
tumor-associated autoantibodies
8
ovarian
6
aabs
5
cancer
5
detection
5
collected months
4
diagnosis usual
4
prior diagnosis
4
months prior
4
cases range
4
invasive cases
4
care ca125
4
estimates close
4
measured electrochemo-luminiscence
4

Similar Publications